Basal-like breast cancer: The road less traveled.
Keywords:
Basal-like breast cancer, gene expression profile, chemotherapyAbstract
     Basal like breast cancer is a heterogeneous subtype having poor disease free and overall survival and distinct type of recurrence and metastasis, identified by gene expression profile study. Current chemotherapy fails to curtail the innate aggressive behavior in the majority of patients. The poor prognosis coupled with a lack of targeted use of therapies is reflected in the high mortality. Future research work will be directed upon better understanding of this entity for tailored therapy.Â
References
1) Gluz O, Liedtke C, Gottschalk N, Pusztai L, Nitz U, Harbeck N. Triple-negative breast cancer: current status and future directions. Ann Oncol. 2009;20: 1913-27.
2) Badve S, Dabbs DJ, Schnitt SJ, Baehner FL, Decker T, Eusebi V, et al. Basal-like and triple-negative breast cancers: A critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol. 2011; 24:157-67.
3) Bertucci F, Finetti P, Cervera N, Esterni B, Hermitte F, Viens P, et al. How basal are triple negative breast cancers? Int J Cancer 2008;123:236–40.
4) Turner NC, Reis-Filho JS, Russell AM, Springall RJ, Ryder K, Steele D, et al. BRCA1dysfunction in sporadic basal-like breast cancer. Oncogene. 2007; 26: 2126 -32.
5) Subhawong AP, Subhawong T, Nassar H, Kouprina N, Begum S, Vang R, et al. Most basal-like breast carcinomas dem-onstrate the same Rb−/p16+ immuno-phenotype as the HPV- related poorly differentiated squamous cell carcinomas which they resemble morphologically. Am J Surg Pathol.2009; 33: 163-75
6) Rakha E, Reis-Filho JS. Basal-like Breast Carcinoma from Expression Profiling to Routine Practice. Arch Pathol Lab Med. 2009; 133:860-8.
7) Ellis IO, Lee AHS, Pinder SE, Rakha EA. Tumours of the breast. In: Fletcher CDM editor. Diagnostic histopathology of tumours. 4th ed. Philadelphia: Elsevier; 2013. p.1098-99.
8) Leidy J, Khan A, Kandil D. Basal-Like Breast Cancer: Update on Clinicopathologic, Immuno-histochemical, and Molecular Features. Arch Pathol Lab Med. 2014; 138:37-43.
9) Rakha E, Reis-Filho JS, Ellis IO. Impact of Basal-Like Breast Carcinoma Determination for a More Specific Therapy. Pathobiology. 2008; 75:95–103.
2) Badve S, Dabbs DJ, Schnitt SJ, Baehner FL, Decker T, Eusebi V, et al. Basal-like and triple-negative breast cancers: A critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol. 2011; 24:157-67.
3) Bertucci F, Finetti P, Cervera N, Esterni B, Hermitte F, Viens P, et al. How basal are triple negative breast cancers? Int J Cancer 2008;123:236–40.
4) Turner NC, Reis-Filho JS, Russell AM, Springall RJ, Ryder K, Steele D, et al. BRCA1dysfunction in sporadic basal-like breast cancer. Oncogene. 2007; 26: 2126 -32.
5) Subhawong AP, Subhawong T, Nassar H, Kouprina N, Begum S, Vang R, et al. Most basal-like breast carcinomas dem-onstrate the same Rb−/p16+ immuno-phenotype as the HPV- related poorly differentiated squamous cell carcinomas which they resemble morphologically. Am J Surg Pathol.2009; 33: 163-75
6) Rakha E, Reis-Filho JS. Basal-like Breast Carcinoma from Expression Profiling to Routine Practice. Arch Pathol Lab Med. 2009; 133:860-8.
7) Ellis IO, Lee AHS, Pinder SE, Rakha EA. Tumours of the breast. In: Fletcher CDM editor. Diagnostic histopathology of tumours. 4th ed. Philadelphia: Elsevier; 2013. p.1098-99.
8) Leidy J, Khan A, Kandil D. Basal-Like Breast Cancer: Update on Clinicopathologic, Immuno-histochemical, and Molecular Features. Arch Pathol Lab Med. 2014; 138:37-43.
9) Rakha E, Reis-Filho JS, Ellis IO. Impact of Basal-Like Breast Carcinoma Determination for a More Specific Therapy. Pathobiology. 2008; 75:95–103.
Downloads
Published
20-07-2014
How to Cite
1.
Bhanvadia VM, Goyal P. Basal-like breast cancer: The road less traveled. Ann of Pathol and Lab Med [Internet]. 2014 Jul. 20 [cited 2024 Nov. 19];1(1):5-7. Available from: https://pacificejournals.com/journal/index.php/apalm/article/view/18
Issue
Section
Editorial
License
Copyright (c) 2014 Viral M Bhanvadia, Prashant Goyal
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).